Japanese censorship confirms the safety and effectiveness of Pfizer vaccine

Kyodo News Agency reported on February 8 that according to relevant sources from the Japanese government, the “Comprehensive Agency for Pharmaceutical Medical Devices” (PMDA) responsible for the national drug review of the coronavirus vaccine of the U.S. pharmaceutical giant Pfizer, which allows simplified reviewers to simplify the reviewer.

Continuing “Special Case Approval”.

The report will be submitted to the special group of the Ministry of Health, Labour and Welfare held on the 12th.

If properly judged, the Minister of Health, Labour will be officially approved on the 15th.